Jackie Syrop

Usage of prescription nonsteroidal anti-inflammatory drugs may increase the risk of atrial fibrillation in older patients, according to the results of a long-term study.

The American Heart Association, American College of Cardiology, and the Heart Rhythm Society issued updated guidelines that include recommendations on new oral anticoagulants for the management of patients with atrial fibrillation.

Although many clinicians presumed patients with poor collateral blood vessel formation near their stroke site should have their blood pressure left high to prevent a second stroke, a study published in Neurology found lowering blood pressure to normal levels reduces subsequent stroke risk more effectively.

A recent study found high-dose multivitamins and minerals taken after myocardial infarction do not significantly reduce subsequent cardiovascular events.

The US Food and Drug Administration approved the first naloxone treatment specifically designed to be given by family members or caregivers to treat a person known or suspected of an opioid overdose.

Researchers at the National Institute of Neurological Disorders and Stroke may have found why patients taking the multiple sclerosis medication natalizumab (Tysabri) have a high risk of developing a rare brain infection that can be fatal.

The loss of the ability to make the amino acid cysteine is the cause of degeneration of the corpus striatum in rodents and people with Huntington's disease, according to a recent study.

Legislation in both the US House of Representatives and the Senate seeks to reverse the FDA's recent approval of Zogenix's hydrocodone-only painkiller Zohydro, because the drug's formulation does not include an abuse deterrent.

A new guidance document on percutaneous coronary intervention (PCI) cites the need for new safety and quality protocols to address the increasing number of PCIs performed at centers with no on-site cardiac surgery backup available.

Nearly 13 million more Americans would be candidates for statin medications to lower cholesterol under the most recent American College of Cardiology-American Heart Association guidelines.

Two European clinical trials are both investigating a theory that multiple sclerosis may be triggered by activation of human endogenous retroviruses.

A new economic analysis finds that the US childhood immunization schedule will prevent 42,000 early deaths and 20 million cases of disease, saving $13.5 billion in direct costs over the lifetime of a single cohort.

With rates of asthma flare-ups were twice as high in September as in August, researchers suggest that people are lax about asthma medication use during the summer before children return to school and are exposed to viral infections.

Just a fifth of people older than 75 years who experience "senior moments" of forgetfulness, memory lapses, and poor judgment go on to develop serious brain-related disorders such as Alzheimer's disease.

The US Food and Drug Administration has approved Cefaly, the first device for use as a preventive treatment for migraine headache.

Deaths attributed to Alzheimer's disease dementia are much larger than what is reported on death certificates and may rival heart disease and cancer.

Thrombosis significantly increases during pregnancy and again during the postpartum period until at least 12 weeks after delivery, according to new research.

Using erythropoietin (EPO) therapy in patients with cardio-renal-anemia syndrome may be associated with more harm than benefit in this population. As new study found a statistically higher mortality rate among EPO users.

Researchers at Yale University have pinpointed the cells and cellular processes that trigger life-threatening pulmonary hypertension, which have been little understood until now.

New research suggests that chronic insomnia is a 24-hour brain condition, rather than a nighttime disorder.

The US Food and Drug Administration (FDA) has approved a new ablation catheter for use in patients with medication-resistant paroxysmal atrial fibrillation.

A 40-member coalition partly comprised of physician experts on opioid addiction treatment and overdose prevention is asking the US Food and Drug Administration to rescind its approval of extended-release Zohydro (hydrocodone bitratrate), given the drug's perceived dangers to the public.

In a recent clinical trial, Celexa (citalopram) reduced agitation in patients with probable Alzheimer's disease (AD) compared to placebo, but the drug also produced severe cognitive and cardiac adverse events that prescribers must consider.

Young women who receive the human papillomavirus (HPV) vaccine have a substantially lower risk of developing precancerous cervical lesions.

A new study suggests antibiotic-glucocorticoid ear drops are superior to oral medications in children who suffer from acute otorrhea following the insertion of tympanostomy tubes for recurrent ear infections.

A US Food and Drug Administration (FDA) advisory panel has not found enough clinical evidence to conclude that naproxen presents a lower risk of cardiovascular (CV) thrombotic events than other nonsteroidal anti-inflammatory drugs (NSAIDs).

Patients who are free of dementia but have 2 parents with late-onset Alzheimer's disease may show signs of the disease in brain scans several years, if not decades, before they display clinical symptoms.

Adding uric acid to standard thrombolytic therapy may reduce the risk of disability among stroke patients.

The US Food and Drug Administration (FDA) has requested clinical trial data from the manufacturer of saxagliptin to investigate the diabetes drug's potential association with heart failure (HF).

In a human model of amyotrophic lateral sclerosis, a toxin released by astrocytes in the brain triggered the loss of motor neurons.